Second Sight Medical Products Inc (NASDAQ:EYES)
| 4.71 BATS BZX Real-Time Price As of 10:06am ET |  -0.83 / -14.91%Today’s Change | 3.42 Today|||52-Week Range 12.72 | -3.68% Year-to-Date |
Latest EYES News | Press Releases
No recent news for Second Sight Medical Products Inc.
Today’s Trading
| Previous close | 5.54 |
| Today’s open | 5.03 |
| Day’s range | 4.63 - 5.19 |
| Volume | 933 |
| Average volume (3 months) | 104,978 |
| Market cap | $80.4M |
Data as of 10:06am ET, 08/19/2022
Growth & Valuation
| Earnings growth (last year) | +62.42% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.18 |
Competitors
| ---- | ||
| EDAPEdap Tms SA | -0.09 | -1.23% |
| APENApollo Endosurgery I... | -0.14 | -2.27% |
| CLGNCollplant Biotechnol... | 0.00 | 0.00% |
Data as of 10:23am ET, 08/19/2022
Financials
| Last reporting date | May 13, 2020 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$8.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Sylmar, California |
Forecasts
